德国哮喘网络队列中重度哮喘患者按需使用低剂量吸入性糖皮质激素/福莫特罗治疗。
As-needed low-dose inhaled corticosteroid/formoterol therapy in patients with severe asthma included in the German Asthma Net cohort.
作者信息
Hinze Christopher Alexander, Ehmann Rainer, Jandl Margret, Milger Katrin, Schmidt Olaf, Schulz Christian, Skowasch Dirk, Welte Tobias, Buhl Roland, Hamelmann Eckard, Idzko Marco, Taube Christian, Korn Stephanie, Suhling Hendrik
机构信息
Department of Respiratory Medicine and Infectious Disease, Hannover Medical School, Hannover, Germany.
Ambulante Pneumologie Stuttgart, Stuttgart, Germany.
出版信息
ERJ Open Res. 2024 Apr 8;10(2). doi: 10.1183/23120541.00741-2023. eCollection 2024 Mar.
Abstract
摘要
https://bit.ly/3SSPX1C. （此为网址，一般保留原样不翻译，如果非要翻译可译为：https://短链接/3SSPX1C 但通常没必要这样做）
相似文献
1
As-needed low-dose inhaled corticosteroid/formoterol therapy in patients with severe asthma included in the German Asthma Net cohort.
ERJ Open Res. 2024 Apr 8;10(2). doi: 10.1183/23120541.00741-2023. eCollection 2024 Mar.
2
As-needed ICS-LABA in Mild Asthma: What Does the Evidence Say?
Drugs. 2019 Nov;79(16):1729-1737. doi: 10.1007/s40265-019-01202-0.
3
Evaluation of Budesonide-Formoterol for Maintenance and Reliever Therapy Among Patients With Poorly Controlled Asthma: A Systematic Review and Meta-analysis.
JAMA Netw Open. 2022 Mar 1;5(3):e220615. doi: 10.1001/jamanetworkopen.2022.0615.
4
Symbicort® Maintenance and Reliever Therapy (SMART) and the evolution of asthma management within the GINA guidelines.
Expert Rev Respir Med. 2018 Mar;12(3):191-202. doi: 10.1080/17476348.2018.1429921. Epub 2018 Feb 5.
5
It is time to change the way we manage mild asthma: an update in GINA 2019.
Respir Res. 2019 Aug 14;20(1):183. doi: 10.1186/s12931-019-1159-y.
6
The cost-effectiveness of as-needed budesonide-formoterol versus low-dose inhaled corticosteroid maintenance therapy in patients with mild asthma in Canada.
Allergy Asthma Clin Immunol. 2021 Oct 12;17(1):108. doi: 10.1186/s13223-021-00610-w.
7
ICS/formoterol in the management of asthma in the clinical practice of pulmonologists: an international survey on GINA strategy.
Asthma Res Pract. 2021 Jan 29;7(1):1. doi: 10.1186/s40733-021-00067-z.
8
Combination formoterol and budesonide as maintenance and reliever therapy versus combination inhaler maintenance for chronic asthma in adults and children.
Cochrane Database Syst Rev. 2013 Dec 16;2013(12):CD009019. doi: 10.1002/14651858.CD009019.pub2.
9
The cost-effectiveness of as-needed budesonide/formoterol versus low-dose inhaled corticosteroid maintenance therapy in patients with mild asthma in the UK.
Respir Med. 2020 Sep;171:106079. doi: 10.1016/j.rmed.2020.106079. Epub 2020 Jul 4.
10
Expert Opinion on Practice Patterns in Mild Asthma After the GINA 2019 Updates: A Major Shift in Treatment Paradigms from a Long-Standing SABA-Only Approach to a Risk Reduction-Based Strategy with the Use of Symptom-Driven (As-Needed) Low-Dose ICS/LABA.
Curr Allergy Asthma Rep. 2022 Oct;22(10):123-134. doi: 10.1007/s11882-022-01038-x. Epub 2022 Jun 11.
本文引用的文献
1
Reduction of daily maintenance inhaled corticosteroids in patients with severe eosinophilic asthma treated with benralizumab (SHAMAL): a randomised, multicentre, open-label, phase 4 study.
Lancet. 2024 Jan 20;403(10423):271-281. doi: 10.1016/S0140-6736(23)02284-5. Epub 2023 Dec 7.
2
Key recommendations for primary care from the 2022 Global Initiative for Asthma (GINA) update.
NPJ Prim Care Respir Med. 2023 Feb 8;33(1):7. doi: 10.1038/s41533-023-00330-1.
3
Landscape of short-acting beta-agonists (SABA) overuse in Europe.
Clin Exp Allergy. 2023 Feb;53(2):132-144. doi: 10.1111/cea.14250. Epub 2022 Dec 5.
4
An Assessment of Quality of Life in Patients With Asthma Through Physical, Emotional, Social, and Occupational Aspects. A Cross-Sectional Study.
Front Public Health. 2022 Sep 1;10:883784. doi: 10.3389/fpubh.2022.883784. eCollection 2022.
5
The German severe asthma patient: Baseline characteristics of patients in the German Severe Asthma Registry, and relationship with exacerbations and control.
Respir Med. 2022 Feb 26;195:106793. doi: 10.1016/j.rmed.2022.106793.
6
Evaluation of Budesonide-Formoterol for Maintenance and Reliever Therapy Among Patients With Poorly Controlled Asthma: A Systematic Review and Meta-analysis.
JAMA Netw Open. 2022 Mar 1;5(3):e220615. doi: 10.1001/jamanetworkopen.2022.0615.
7
Prevalence of overuse of short-acting beta-2 agonists (SABA) and associated factors among patients with asthma in Germany.
Respir Res. 2021 Apr 16;22(1):108. doi: 10.1186/s12931-021-01701-3.
8
SMART and as-needed therapies in mild-to-severe asthma: a network meta-analysis.
Eur Respir J. 2020 Sep 10;56(3). doi: 10.1183/13993003.00625-2020. Print 2020 Sep.
9
GINA 2019: a fundamental change in asthma management: Treatment of asthma with short-acting bronchodilators alone is no longer recommended for adults and adolescents.
Eur Respir J. 2019 Jun 27;53(6). doi: 10.1183/13993003.01046-2019. Print 2019 Jun.
10
[Epidemiology and costs of asthma in Germany - a systematic literature review].
Pneumologie. 2014 Aug;68(8):557-67. doi: 10.1055/s-0034-1377225. Epub 2014 Jul 8.
Zotero 插件